1Roland H. Mammalian oxygen sensing, signaling and gene regulation [J]. Experimental Biologh, 2000; 230:1253.
2Leyland- Jones B. Evidence for erythropoietin as a molecular targeting agent [ J ]. Semin Oncol, 2002; 29 (3 Suppl 11 ) :145.
3Duffy JP, Eibl G, Rebcr HA, et al. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer [J].Mol Cancer, 2003; 2 (1): 12.
4Semenm GL. Targeting HIF- 1 for cancer therapy [ J]. Nat Rev Cancer, 2003; 3 (10): 721.
5Goda N, Ryan HE, Khadivi B, et al. Hypoxia- inducible factor- 1alpha is essential for cell cycle arrest during hypoxia[J]. Mol Cell Biol, 2003; 23 (1): 359.
6Acs G, Zhang PJ, McGrath CM, et al. Hypoxia- inducible erythropoietin signalling in squamous dysplasisa and squmous cell carcinogenesis and tumor progression [J]. Am J Pathol,2003; 162 (6): 1789.
7Bim P, Gatterbauer G, et al. Expression of hypoxia- inducible fabtorla in oligodendrogliomss [J]. Cancer, 2001; 92(1): 165.
8Zagzag D, Zhong H, Scalzhi JM, et al. Expression of hypoxia- inducible factor lain brain tumors [ J]. Cancer,2000; 88 (11): 2606.
9Sonderguard KL, Hilton DA, Penney M, et al. Expression of hypoxia- inducible factor lalpha in tumor of patients with glioblastoma [ J]. Neuropathol Appl Neurobiol, 2002; 28(3) : 210.
10Zhong H, Angelo M, Langhner D, et al. Overexpression of hypoxia- inducible factor lalpha in common human cancers and their metastases [J]. Cancer Res 1999; 59 (22) : 5830.
6Bimer P,Schindl M,Obermair A,et al.Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer[J].Cancer Res,2000,60(17):4693-4696.
7Maeda K,Chung YS,Onoda N,et al.Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special refernce to prognosis[J].Cancer,1994,73:528-533.
8Semenza GL.Targeting HIF-1α for cancer therapy[J].Nat Rev Cancer,2003,3(10):721-732.
9Kaur B,Khwaja FW,Severson EA,et al.Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis[J].Neuro-oncol,2005,7 (2):134-153.
10Gillece MH,Dazzi F.Donor lymphocyte infusions for patients who relapse after allongeic stem cell transplantation for chronic myeloid leukemia[J].Leuk Lymphoma,2003,4:23-28.
